S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

INO Inovio Pharmaceuticals Inc New

2.00

0.00 (0.00%)

Pre Market

Last Updated: 03:08:16

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Inovio Pharmaceuticals (NASDAQ:INO)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Inovio Pharmaceuticals Charts.

Inovio Pharmaceuticals (NASDAQ:INO)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Inovio Pharmaceuticals Charts.

Inovio Pharmaceuticals Inc New News

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Wednesday 5 February 2025 (1 day ago) • Edgar (US Regulatory)

INOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Wednesday 29 January 2025 (1 week ago) • PR Newswire (US)

INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments
Thursday 9 January 2025 (4 weeks ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 18 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 16 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 13 December 2024 (2 months ago) • Edgar (US Regulatory)

INOVIO Announces Pricing of $30 Million Public Offering
Friday 13 December 2024 (2 months ago) • PR Newswire (US)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Thursday 12 December 2024 (2 months ago) • Edgar (US Regulatory)

INOVIO Announces Proposed Public Offering
Thursday 12 December 2024 (2 months ago) • PR Newswire (US)

New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial
Tuesday 3 December 2024 (2 months ago) • PR Newswire (US)

INOVIO Reports Inducement Grant Under Inducement Plan
Friday 29 November 2024 (2 months ago) • PR Newswire (US)

INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Thursday 14 November 2024 (3 months ago) • PR Newswire (US)

More Inovio Pharmaceuticals Inc New News Articles

Comp Gobain Tf 1% Mz25 Eur

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions